AdvanSource Biomaterials Corporation (NYSE Alternext US: ASB), a
leading developer of advanced polymer materials for a broad range of
medical devices, announced today that it will release its results for
the third quarter of fiscal 2009 before the market opens on Wednesday,
February 18, 2009. Following the release, the Company will host a
conference call for investors at 2:30 p.m. ET (11:30 a.m. PT) to discuss
its fiscal third quarter results as well as recent developments. The
February 18 date is later than usual due to travel commitments for a
major industry conference and expo in California during the prior week.
Participants should dial-in (866) 206-7204 Conference ID# 1326033 or
(703) 639-1114 outside the U.S. Please dial-in 10 minutes
before the call is scheduled to begin. A replay of the call will be
available for two weeks following the call at (888) 266-2081 ID# 1326033
and on the Company’s website.
About AdvanSource Biomaterials Corporation
AdvanSource Biomaterials Corporation manufactures advanced polymer
materials which provide critical characteristics in the design and
development of medical devices. The Company’s biomaterials are used in
devices that are designed for treating a broad range of anatomical sites
and disease states. AdvanSource’s business model leverages its
proprietary materials science technology and manufacturing expertise in
order to expand its product sales and royalty and license fee income.
The Company is conducting a clinical trial for regulatory approval at
two sites in Europe for its CardioPass™ synthetic coronary bypass graft.
More information about AdvanSource is available at its website: www.advbiomaterials.com
AdvanSource Biomaterials Corporation
Eric Walters, 978-657-0075
Vice
President & Chief Financial Officer
info@advbiomaterials.com
or
VMW
Corporate & Investor Relations
Sylvia Dresner, 212-616-6161
Senior
Vice President
info@vmwcom.com
